Koninklijke Philips N.V.

NYSE:PHG Stock Report

Market Cap: US$23.4b

Koninklijke Philips Past Earnings Performance

Past criteria checks 0/6

Koninklijke Philips's earnings have been declining at an average annual rate of -55.8%, while the Medical Equipment industry saw earnings growing at 12% annually. Revenues have been declining at an average rate of 0.7% per year.

Key information

-55.8%

Earnings growth rate

-55.6%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate-0.7%
Return on equity-3.9%
Net Margin-2.6%
Next Earnings Update11 Feb 2025

Recent past performance updates

Recent updates

Philips: Looking Undervalued After Q3 Earnings Drop

Oct 28

Philips: Moving Out Of Intensive Care

Oct 09

Philips Q2 Earnings: A Focus On Core Strengths Is The Winning Strategy

Jul 29

Philips Stock Surges: Risk Remains On Respironics, But With Investment Potential

Jun 28

Koninklijke Philips: Major Overhang Removed

May 01

Koninklijke Philips: Still On The Cautious Line

Jan 24

Philips Q3 Earnings: Getting More Attractive (Rating Upgrade)

Oct 25

Koninklijke Philips: Hold For Now

Oct 12

Philips: A Healthcare Leader But A Very Risky Investment

Sep 20

Revenue & Expenses Breakdown

How Koninklijke Philips makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

NYSE:PHG Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2418,039-4695,1271,724
30 Jun 2418,133-5555,1641,737
31 Mar 2418,140-7945,1481,781
31 Dec 2318,169-4565,1531,890
30 Sep 2318,529-6095,2451,820
30 Jun 2318,368-2,0355,3261,974
31 Mar 2318,076-2,1325,3082,002
31 Dec 2217,827-1,6215,3021,957
30 Sep 2217,349-1,3634,9721,974
30 Jun 2217,1944024,8541,790
31 Mar 2217,2474914,7851,776
31 Dec 2117,1566084,8651,806
30 Sep 2119,6691,1735,2501,757
30 Jun 2117,7038114,6271,630
31 Mar 2119,6691,1475,0981,741
31 Dec 2017,3139914,5641,691
30 Sep 2019,4921,1425,0941,724
30 Jun 2018,3279664,8571,660
31 Mar 2019,4901,0555,2121,691
31 Dec 1917,1479844,5821,639
30 Sep 1919,1101,3545,2191,761
30 Jun 1918,7141,4525,0861,707
31 Mar 1918,3301,3815,1041,701
31 Dec 1818,1211,3035,0031,683
30 Sep 1817,8381,0224,9441,640
30 Jun 1817,6808714,9151,676
31 Mar 1817,6878084,8321,672
31 Dec 1717,7808144,8311,660
30 Sep 1717,7838304,7541,731
30 Jun 1717,7928764,7201,708
31 Mar 1724,7241,1056,5942,037
31 Dec 1617,4227884,6231,648
30 Sep 1619,2112185,4351,741
30 Jun 1620,8902485,9201,784
31 Mar 1622,7323656,4041,855
31 Dec 1516,8061455,1211,562
30 Sep 1523,6855906,4701,820
30 Jun 1523,0432286,2751,721
31 Mar 1522,0381916,0011,638
31 Dec 1421,3912255,9301,635
28 Sep 1420,3734375,7121,498
29 Jun 1420,7748395,7421,575
30 Mar 1421,4379745,8341,601
31 Dec 1321,9901,0315,9031,657

Quality Earnings: PHG is currently unprofitable.

Growing Profit Margin: PHG is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: PHG is unprofitable, and losses have increased over the past 5 years at a rate of 55.8% per year.

Accelerating Growth: Unable to compare PHG's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: PHG is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (12.9%).

Return on Equity

High ROE: PHG has a negative Return on Equity (-3.93%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 15:42
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Koninklijke Philips N.V. is covered by 54 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Wim GilleABN AMRO Bank N.V.
Sumit SayalAlphaValue
Fabrizio SpagnaAxia Financial Research